companydata.dkGXP PHARMAID ApS: Financial statements 2014
CVR: 29615861
GXP PHARMAID ApS (CVR 29615861) has filed annual accounts for 2014. In 2014, the company reported a gross profit of DKK 3,604,083 and a net result of DKK 380,379 compared with DKK 450,698 the year before. That is an increase of 56.3% compared with the year before. Equity amounted to DKK 1,114,147. The solvency ratio was 43.6%.
- Gross Profit
- 3,604,083 kr.
- Profit/Loss
- 380,379 kr.
- Equity
- 1,114,147 kr.
- Total Assets
- 2,555,211 kr.
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2014 | - | 3.6 mio. | 380 t. | 1.1 mio. | - |
| 2013 | - | 2.3 mio. | 451 t. | 1.1 mio. | - |
| 2012 | - | 2.1 mio. | - | - | - |
Events in 2014
As of August 12, 2014, Nusret Asanovski has left the board of directors of GXP PHARMAID ApS.
As of August 12, 2014, Jonas Evjenios Markou has left the board of directors of GXP PHARMAID ApS.
As of August 12, 2014, Mogens Birch-Larsen has left the board of directors of GXP PHARMAID ApS.
GXP PHARMAID ApS has published its annual report for 2013. Gross profit came to DKK 2,306,234, and the net result was DKK 450,698.
About GXP PHARMAID ApS
GXP PHARMAID ApS is a Danish company of the type Anpartsselskab based in Brønshøj, founded in 2006. The company is registered under the industry Anden teknisk rådgivning. The management consists of Nusret Asanovski. The company is owned by MAC ANDORBY ApS. The company has 2 employees. In 2024, the company reported a gross profit of DKK 1,340,825 and a net result of DKK 216,532 compared with DKK 513,163 the year before. Equity amounted to DKK 1,096,211.